title: Mimics of the binding sites of opioid receptors obtained by molecular imprinting of enkephalin and morphine.
abstract: Molecular imprinting of morphine and the endogenous neuropeptide [Leu5]enkephalin (Leu-enkephalin) in methacrylic acid-ethylene glycol dimethacrylate copolymers is described. Such molecular imprints possess the capacity to mimic the binding activity of opioid receptors. The recognition properties of the resultant imprints were analyzed by radioactive ligand binding analysis. We demonstrate that imprinted polymers also show high binding affinity and selectivity in aqueous buffers. This is a major breakthrough for molecular imprinting technology, since the binding reaction occurs under conditions relevant to biological systems. The antimorphine imprints showed high binding affinity for morphine, with Kd values as low as 10(-7) M, and levels of selectivity similar to those of antibodies. Preparation of imprints against Leu-enkephalin was greatly facilitated by the use of the anilide derivative rather than the free peptide as the print molecule, due to improved solubility in the polymerization mixture. Free Leu-enkephalin was efficiently recognized by this polymer (Kd values as low as 10(-7) M were observed). Four tetra- and pentapeptides, with unrelated amino acid sequences, were not bound. The imprints showed only weak affinity for two D-amino acid-containing analogues of Leu-enkephalin. Enantioselective recognition of the L-enantiomer of phenylalanylglycine anilide, a truncated analogue of the N-terminal end of enkephalin, was observed.
authors.affiliation: Department of Pure and Applied Biochemistry, University of Lund, Sweden.
authors.forename: L I
authors.initials: LI
authors.lastname: Andersson
authors.forename: R
authors.initials: R
authors.lastname: Müller
authors.forename: G
authors.initials: G
authors.lastname: Vlatakis
authors.forename: K
authors.initials: K
authors.lastname: Mosbach
mesh_terms: D000595:Amino Acid Sequence; D001665:Binding Sites; D001667:Binding, Competitive; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives; D004744:Enkephalin, Methionine; D004745:Enkephalins; D007700:Kinetics; D008024:Ligands; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009020:Morphine; D009842:Oligopeptides; D011957:Receptors, Opioid / Q000737:chemistry* / Q000378:metabolism*; D018822:alpha-Endorphin
chemical_list: D004745:Enkephalins; D008024:Ligands; D009842:Oligopeptides; D011957:Receptors, Opioid; D004744:Enkephalin, Methionine; D004743:Enkephalin, Leucine; D018822:alpha-Endorphin; D016308:Enkephalin, Leucine-2-Alanine; C030279:enkephalinamide-Leu, Ala(2)-; D009020:Morphine